Trials / Completed
CompletedNCT04925921
AVAVA SR-1 Wrinkles and BPL Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- AVAVA, Inc. · Industry
- Sex
- All
- Age
- 22 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This study is being conducted to evaluate the safety and efficacy of a laser called the SR-1 Skin Treatment System, or SR-1 Laser, for the treatment of wrinkles and pigmented spots. Participants will be treated with the SR-1 Laser 3 or 4 times with each treatment spaced 4-6 weeks apart. The improvement in wrinkles and pigmented spots will be evaluated 1 and 3 months after the final treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | SR-1 Laser | 3-4 treatments at 4-6 week intervals |
Timeline
- Start date
- 2021-05-10
- Primary completion
- 2021-12-22
- Completion
- 2022-07-25
- First posted
- 2021-06-14
- Last updated
- 2023-12-12
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04925921. Inclusion in this directory is not an endorsement.